Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis
Top Cited Papers
- 25 April 2005
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 57 (5), 664-678
- https://doi.org/10.1002/ana.20464
Abstract
Dermatomyositis has been modeled as an autoimmune disease largely mediated by the adaptive immune system, including a local humorally mediated response with B and T helper cell muscle infiltration, antibody and complement-mediated injury of capillaries, and perifascicular atrophy of muscle fibers caused by ischemia. To further understand the pathophysiology of dermatomyositis, we used microarrays, computational methods, immunohistochemistry and electron microscopy to study muscle specimens from 67 patients, 54 with inflammatory myopathies, 14 with dermatomyositis. In dermatomyositis, genes induced by interferon-α/β were highly overexpressed, and immunohistochemistry for the interferon-α/β inducible protein MxA showed dense staining of perifascicular, and, sometimes all myofibers in 8/14 patients and on capillaries in 13/14 patients. Of 36 patients with other inflammatory myopathies, 1 patient had faint MxA staining of myofibers and 3 of capillaries. Plasmacytoid dendritic cells, potent CD4+ cellular sources of interferon-α, are present in substantial numbers in dermatomyositis and may account for most of the cells previously identified as T helper cells. In addition to an adaptive immune response, an innate immune response characterized by plasmacytoid dendritic cell infiltration and interferon-α/β inducible gene and protein expression may be an important part of the pathogenesis of dermatomyositis, as it appears to be in systemic lupus erythematosus. Ann Neurol 2005;57:664–678Keywords
This publication has 38 references indexed in Scilit:
- Uncertainties in the pathogenesis of adult dermatomyositisCurrent Opinion in Neurology, 2004
- 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The NetherlandsNeuromuscular Disorders, 2004
- Polymyositis and dermatomyositisThe Lancet, 2003
- Molecular profiles of inflammatory myopathiesNeurology, 2002
- IDIOPATHIC INFLAMMATORY MYOPATHIESNeurologic Clinics, 1997
- Inclusion body myositis and myopathiesAnnals of Neurology, 1995
- Microvascular Deposition of Complement Membrane Attack Complex in DermatomyositisThe New England Journal of Medicine, 1986
- Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cellsAnnals of Neurology, 1984
- Experimental ischemic myopathyJournal of the Neurological Sciences, 1974
- Experimental Myopathy After Microarterial EmbolizationArchives of Neurology, 1970